Stocks · Health care · Biological Products, (No Diagnostic Substances)

Voyager Therapeutics, Inc.

VYGR Clue Score26

United States Fiscal year ends December CIK 0001640266 Results filed 6 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

24 insiders · 123 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Neurocrine Biosciences Inc entity

10% owner

$89.03M (2)

—

+$89.03M

8,575,316

13.92%

$33.19M

—

Third Rock Ventures III, L.P. entity

10% owner

—

$12.72M (13)

−$12.72M

3,185,291

5.17%

$12.33M

−71.2%

EcoR1 Capital, LLC entity

10% owner

$2.66M (2)

$7.14M (3)

−$4.48M

3,851,507

6.25%

$14.91M

−9.9%

Jane Henderson

Sr. V.P. & CFO, Corp. Dev.

—

$1.03M (4) scheduled

−$1.03M

0

0.0000%

$0.00

—

Bernard Ravina

Chief Medical Officer

—

$848.62K (10)

−$848.62K

0

0.0000%

$0.00

−100.0%

Alfred Sandrock

President and CEO

—

$620.38K (10)

−$620.38K

472,549

0.7669%

$1.83M

+3,607%

Dinah Ph.D. Sah

Chief Scientific Officer

—

$468.69K (1) scheduled

−$468.69K

163,688

0.2656%

$633.47K

−3.7%

Robin Swartz

President

—

$451.36K (18)

−$451.36K

267,988

0.4349%

$1.04M

+311.6%

Todd Alfred Carter

Chief Scientific Officer

—

$367.89K (18) scheduled

−$367.89K

178,718

0.2900%

$691.64K

+393.8%

Andre Turenne

President & CEO

—

$293.26K (3)

−$293.26K

322,375

0.5232%

$1.25M

—

Robert W. Hesslein

Senior VP & General Counsel

—

$258.55K (13)

−$258.55K

102,200

0.1659%

$395.51K

—

Peter P. Pfreundschuh

Chief Financial Officer

—

$122.91K (2)

−$122.91K

175,669

0.2851%

$679.84K

—

James A Geraghty

Director

$113.10K (2)

—

+$113.10K

76,588

0.1243%

$296.40K

+8.5%

Toby Ferguson

Chief Medical Officer

—

$105.46K (2)

−$105.46K

183,914

0.2985%

$711.75K

—

Michael J Higgins

Director

—

$93.07K (1)

−$93.07K

31,314

0.0508%

$121.19K

—

Allison Dorval

Chief Financial Officer

—

$91.20K (3)

−$91.20K

109,894

0.1783%

$425.29K

+4,047%

Omar Khwaja

See remarks

—

$85.77K (3)

−$85.77K

120,509

0.1956%

$466.37K

—

Sandell Jacquelyn Fahey

Chief Legal Officer

—

$54.31K (2)

−$54.31K

123,143

0.1998%

$476.56K

—

Nathan D. Jorgensen

Chief Financial Officer

—

$54.24K (2) scheduled

−$54.24K

151,416

0.2457%

$585.98K

—

Matthew P. Ottmer

Chief Operating Officer

—

$49.75K (1)

−$49.75K

26,276

0.0426%

$101.69K

—

Julie Burek

VP, Finance

—

$35.47K (6)

−$35.47K

52,458

0.0851%

$203.01K

+58.9%

Glenn Pierce

Director

$92.20K (1)

$63.73K (1)

+$28.47K

21,788

0.0354%

$84.32K

—

Mark J Levin

Director

—

—

—

6,427,874

10.43%

$24.88M

−42.1%

Gregory L. Shiferman

SVP and General Counsel

—

—

—

50,000

0.0811%

$193.50K

—